Illinois Municipal Retirement Fund Buys 3,411 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Illinois Municipal Retirement Fund boosted its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 7.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 47,409 shares of the company’s stock after acquiring an additional 3,411 shares during the quarter. Illinois Municipal Retirement Fund owned approximately 0.06% of Pediatrix Medical Group worth $622,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. State Street Corp raised its position in shares of Pediatrix Medical Group by 1.4% in the 3rd quarter. State Street Corp now owns 3,540,791 shares of the company’s stock valued at $41,038,000 after acquiring an additional 50,597 shares during the period. Nordea Investment Management AB raised its position in shares of Pediatrix Medical Group by 51.6% in the 4th quarter. Nordea Investment Management AB now owns 263,633 shares of the company’s stock valued at $3,504,000 after acquiring an additional 89,739 shares during the period. Barclays PLC raised its position in shares of Pediatrix Medical Group by 302.9% in the 3rd quarter. Barclays PLC now owns 142,087 shares of the company’s stock valued at $1,646,000 after acquiring an additional 106,817 shares during the period. Franklin Resources Inc. acquired a new stake in shares of Pediatrix Medical Group in the 3rd quarter valued at approximately $598,000. Finally, Principal Financial Group Inc. raised its position in shares of Pediatrix Medical Group by 14.1% in the 3rd quarter. Principal Financial Group Inc. now owns 513,618 shares of the company’s stock valued at $5,953,000 after acquiring an additional 63,581 shares during the period. Institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Stock Down 2.1 %

MD opened at $14.46 on Tuesday. Pediatrix Medical Group, Inc. has a fifty-two week low of $6.62 and a fifty-two week high of $17.67. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.42 and a current ratio of 1.60. The company has a market capitalization of $1.24 billion, a P/E ratio of -12.05, a P/E/G ratio of 1.74 and a beta of 1.57. The stock has a fifty day moving average of $13.99 and a 200-day moving average of $13.19.

Pediatrix Medical Group (NYSE:MD) last posted its earnings results on Thursday, February 20th. The company reported $0.49 earnings per share for the quarter, topping analysts’ consensus estimates of $0.37 by $0.12. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The company had revenue of $502.36 million during the quarter, compared to the consensus estimate of $486.22 million. On average, equities analysts expect that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Analyst Ratings Changes

A number of brokerages recently weighed in on MD. Deutsche Bank Aktiengesellschaft increased their price target on shares of Pediatrix Medical Group from $9.00 to $15.00 and gave the company a “hold” rating in a research report on Monday, November 4th. Truist Financial raised their target price on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a “hold” rating in a report on Friday, February 21st. Macquarie initiated coverage on shares of Pediatrix Medical Group in a report on Monday, December 16th. They set an “outperform” rating and a $18.00 target price on the stock. Mizuho raised their target price on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a “neutral” rating in a report on Tuesday, November 19th. Finally, Jefferies Financial Group raised their price target on shares of Pediatrix Medical Group from $14.00 to $18.00 and gave the stock a “buy” rating in a research note on Tuesday, November 5th. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $17.08.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.